Court dismisses class action suit against Mylan regarding EpiPen
July 27, 2021 at 09:05 AM EDT
Viatris said it will continue to “defend itself vigorously should there be any further proceedings in the case.”
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|